The gene expression market was valued at $8,505.71 million in 2021 and is estimated to reach $17,960.77 million by 2031, exhibiting a CAGR of 7.7% from 2022 to 2031. Gene expression is the process by which the information encoded in a gene is turned into a function. This mostly occurs via the transcription of RNA molecules that code for proteins or non-coding RNA molecules that serve other functions. Gene expression can be thought of as an “on/off switch” to control when and where RNA molecules and proteins are made and as a “volume control” to determine how much of those products are made.
The key factors that drive the growth of the gene expression market is the rising demand for personalized medicine and technological advancement in genomics such as next-generation sequencing and CRISPR technology that have enabled the development of gene expression products with higher precision and accuracy. For instance, in March 2021 Thermo Fisher Scientific announced the completion of the U.S. Food and Drug Administration (FDA) listing for the applied biosystems QuantStudio 5 Dx Real-Time PCR System. The QuantStudio 5 is a comprehensive gene expression platform designed to provide high-throughput gene expression data on the go. This innovative product enables clinical laboratories and assay developers to meet testing demands and enhance molecular diagnostics workflows. Thus, the rise in the prevalence of chronic disease, and development of technologically advanced solutions is anticipated to boost the growth of the market.
However, the high cost of instruments for gene expression and lack of skilled professional hampers the market growth. Conversely, increased investments in R&D for the development of new technologies for tissue-specific or cell-specific gene expression analysis, as well as increase in the prevalence of chronic and genetic diseases may open up the new market potential for gene expression and are expected to provide a lucrative opportunity for the growth of the market during the forecast period.
The gene expression market is segmented on the basis of product, application, end-user, and region. By product, the market is segmented into consumables and instruments. The instruments are further bifurcated into polymerase chain reaction, next generation sequencing, and DNA microarrays and others. As per application, the market is bifurcated into drug discovery and diagnostics. According to end user, it is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players that operate in the gene expression market are Illumina Inc., Agilent Technologies, Thermo Fisher Scientific Inc., PerkinElmer Inc., Oxford Nanopore Technologies, QIAGEN, Bio-Rad Laboratories Inc., PacBio, Promega Corporation, and F. Hoffmann-La Roche Ltd.
The key factors that drive the growth of the gene expression market is the rising demand for personalized medicine and technological advancement in genomics such as next-generation sequencing and CRISPR technology that have enabled the development of gene expression products with higher precision and accuracy. For instance, in March 2021 Thermo Fisher Scientific announced the completion of the U.S. Food and Drug Administration (FDA) listing for the applied biosystems QuantStudio 5 Dx Real-Time PCR System. The QuantStudio 5 is a comprehensive gene expression platform designed to provide high-throughput gene expression data on the go. This innovative product enables clinical laboratories and assay developers to meet testing demands and enhance molecular diagnostics workflows. Thus, the rise in the prevalence of chronic disease, and development of technologically advanced solutions is anticipated to boost the growth of the market.
However, the high cost of instruments for gene expression and lack of skilled professional hampers the market growth. Conversely, increased investments in R&D for the development of new technologies for tissue-specific or cell-specific gene expression analysis, as well as increase in the prevalence of chronic and genetic diseases may open up the new market potential for gene expression and are expected to provide a lucrative opportunity for the growth of the market during the forecast period.
The gene expression market is segmented on the basis of product, application, end-user, and region. By product, the market is segmented into consumables and instruments. The instruments are further bifurcated into polymerase chain reaction, next generation sequencing, and DNA microarrays and others. As per application, the market is bifurcated into drug discovery and diagnostics. According to end user, it is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players that operate in the gene expression market are Illumina Inc., Agilent Technologies, Thermo Fisher Scientific Inc., PerkinElmer Inc., Oxford Nanopore Technologies, QIAGEN, Bio-Rad Laboratories Inc., PacBio, Promega Corporation, and F. Hoffmann-La Roche Ltd.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the gene expression market analysis from 2021 to 2031 to identify the prevailing gene expression market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the gene expression market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global gene expression market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Others
By Products
- Consumable
- Instruments
- Type
- Polymerase Chain Reaction
- Next Generation Sequencing
- DNA Microarrays
- Others
By Application
- Drug Discovery
- Diagnostics
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Illumina Inc.
- PacBio
- Oxford Nanopore Technologies
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN
- F. Hoffmann-La Roche Ltd.
- Promega Corporation
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: GENE EXPRESSION MARKET, BY PRODUCTS
CHAPTER 5: GENE EXPRESSION MARKET, BY APPLICATION
CHAPTER 6: GENE EXPRESSION MARKET, BY END USER
CHAPTER 7: GENE EXPRESSION MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report titled, “Gene expression Market," the gene expression market valued for $8,505.71 million in 2021 and is estimated to reach $17,960.77 million by 2031, exhibiting a CAGR of 7.7% from 2022 to 2031. Gene expression is an important life process through which gene sequences are transcribed into functional gene products such as functional RNAs or proteins. It plays an important role in functioning and development of an organism and provides a connection between gene-encoded information and a functional gene end-product. It is determined by deciphering the gene information during the transcription and translation process and is very useful in identifying the molecular signature of a disease and for determining biomarker in correlation with dose dependent cellular responses on exposure to drug or therapeutic candidate.Key factors driving the growth of the gene expression market include the increase in the prevalence of genetic disorders, growing application of gene expression in drug discovery and rise in the demand of personalized medicine for genetic disorders. A mutation in a gene that codes for a protein involved in a metabolic pathway can lead to a metabolic disorder, such as cystic fibrosis or phenylketonuria. In addition, changes in gene expression can cause abnormal development of organs and tissues, resulting in birth defects. By understanding how gene expression works, scientists can identify potential treatments for genetic disorders, such as gene therapy and targeted drug therapy. Thus, the rise in the prevalence of rare genetic disorder increases the demand for gene therapy that boost the growth of the market. For instance, according to the report published by Centers for Disease Control and Prevention, in December 2022 it has been estimated that chromosomal defect affected 531 babies with trisomy 13 (Patau syndrome) which is 1 in every 7,409 births, 1,187 babies were affected by trisomy 18 (Edwards syndrome), and 5,568 babies acquired trisomy 21 (Down syndrome) in U.S. Thus, the increasing incidence of rare genetic and chromosomal disorder is anticipated to increase the demand for gene expression therapy, thereby driving the growth of the market. The increase in the demand for personalized medicine is driving the growth of the gene expression market. Personalized medicine is an approach to healthcare that uses genetic information to identify the most effective treatments for a person's particular genetic make-up. Thus, with the help of gene expression data, physician can better understand the patient's individual risks and vulnerabilities and tailor treatments more specifically to their needs. This increases the demand for gene expression technologies and services, particularly in the area of diagnostics that propels the growth of the market. In addition, the rise in the development of new technologies and techniques such as high-throughput sequencing and next-generation sequencing is increasing the accuracy and speed of gene expression analysis, leading to more precise diagnoses. These are the major factors that propel the growth of the market over the forecast period.
The market also offers growth opportunities to the key players in the market. The rise in prevalence of genetic disorders and cancers in developing nations (such as Brazil, India, and China) will increase the demand for personalized medicine is anticipated to provide lucrative growth opportunities for the market. For instance, according to the report published in MedlinePlus, in 2021, it has been estimated that, about 1 in 200,000 people in the U.S. are diagnosed with gene variant syndrome each year. Whereas, an estimated 15,000 people worldwide were diagnosed with genetic disease last year. In addition, approximately 1 in 100,000 people in the U.S. have genetic disorders at the present time. About 100,000 children worldwide currently have genetic disorders. Moreover, the surge in geriatric populations and increasing advancements in genomics and technological developments in gene expression techniques are the factors that propel the market growth in the upcoming years. Furthermore, the emerging nations need to focus on the adoption of the latest technologies for gene expression that are crucial to treat the genetic disorders. Therefore, technological advancements and rising awareness among people toward rising prevalence of genetic disorder and the availability of gene expression-based instruments and reagents to cure the disease offer lucrative opportunities for the growth of the gene expression market.
The gene expression market is segmented on the basis of product, application, end-user, and region. By product, the market is segmented into consumables and instruments. The instruments are further bifurcated into polymerase chain reaction, next generation sequencing, and DNA microarrays and others. As per application, the market is bifurcated into drug discovery and diagnostics. According to end user, it is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players that operate in the gene expression market are Illumina Inc., Agilent Technologies, Thermo Fisher Scientific Inc., PerkinElmer Inc., Oxford Nanopore Technologies, QIAGEN, Bio-Rad Laboratories Inc., PacBio, Promega Corporation, and F. Hoffmann-La Roche Ltd.
Key Market Insights
- By product, the consumables segment is expected to experience rapid growth in the market and is estimated to reach $9,540.82 million by 2031, with a CAGR of 8.0%. However, the instruments segment is estimated to be growing with a significant CAGR of 7.3% during the forecast period.
- By application, the diagnostics segment dominated the global market. However, the drug discovery segment is expected to grow with a significant CAGR of 7.2% during the forecast period.
- By end user, the pharmaceutical & biotechnology companies segment dominated the global market. However, the academic research & institutes segment is expected to grow with a significant CAGR of 7.9% during the forecast period.
- Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 9.1% during the forecast period.
Companies Mentioned
- Illumina Inc.
- PacBio
- Oxford Nanopore Technologies
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN
- F. Hoffmann-La Roche Ltd.
- Promega Corporation
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Related Reports
From
From
Gene Expression Market Report and Forecast 2024-2032
- Report
- 140 Pages
- Global
From
Gene Expression Analysis Market by Offering, Application, End-user - Global Forecast 2025-2030
- Report
- 198 Pages
- Global
From
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
